{"id":11679,"date":"2024-09-25T07:00:00","date_gmt":"2024-09-25T05:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/"},"modified":"2024-09-25T07:00:00","modified_gmt":"2024-09-25T05:00:00","slug":"irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/","title":{"rendered":"IRLAB presenterar vid konferensen International Congress of Parkinson’s Disease and Movement Disorders\u00ae(MDS) 2024"},"content":{"rendered":"
\n

G\u00f6teborg den 25 september, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelar idag att f\u00f6retaget kommer att presentera en poster p\u00e5 \u00e5rets upplaga av konferensen International Congress of Parkinson's Disease and Movement Disorders (MDS) 27 september\u20131 oktober i Philadephia, USA.<\/strong><\/p>\n<\/div>\n

\n

IRLAB:s poster beskriver en metaanalys av tv\u00e5 randomiserade kontrollerade fas II-studier som utv\u00e4rderar effekten av mesdopetam (IRL790) vid levodopainducerade dyskinesier och har titeln \u201dMeta-Analysis of Two Randomized Controlled Trials Assessing the Efficacy of Mesdopetam (IRL790) in Levodopa-Induced Dyskinesia in Parkinson\u2019s Disease.\u201d<\/p>\n

Postern kommer att presenteras av IRLAB:s medarbetare Fredrik Hansson, Director Clinical\u00a0Science & Biometrics och Susanna Waters, Director Systems Pharmacology den 29 september\u20132024, kl. 13-15.<\/p>\n

Medf\u00f6rfattare till postern \u00e4r Erik Werner, Nicholas Waters, Joakim Tedroff.<\/p>\n

F\u00f6r mer information om konferensen, bes\u00f6k g\u00e4rna\u00a0https:\/\/www.mdscongress.org\/<\/a><\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Kristina Torfg\u00e5rd, VD
Tel: +46 730 60 70 99
E-post: kristina.torfgard@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar en portf\u00f6lj av transformativa behandlingar f\u00f6r alla stadier av Parkinsons sjukdom. Bolaget har sitt ursprung i Nobelpristagaren Prof. Arvid Carlssons forskargrupp och uppt\u00e4ckten av ett samband mellan st\u00f6rningar i hj\u00e4rnans signalsubstanser och hj\u00e4rnans sjukdomar. Mesdopetam (IRL790), under utveckling f\u00f6r behandling av levodopa-inducerade dyskinesier, har slutf\u00f6rt Fas IIb och \u00e4r i f\u00f6rberedelse f\u00f6r Fas III. Pirepemat (IRL752), befinner sig f\u00f6r n\u00e4rvarande i Fas IIb, och utv\u00e4rderas f\u00f6r sin effekt p\u00e5 balans och fallfrekvens vid Parkinson. IRL757, en substans som utvecklas f\u00f6r behandling av apati vid neurodegenerativa sjukdomar, befinner sig i Fas I. Dessutom utvecklar bolaget de tv\u00e5 prekliniska programmen IRL942 och IRL1117 mot Fas I-studier. IRLAB:s pipeline har genererats av bolagets egenutvecklade systembiologibaserade forskningsplattform Integrative Screening Process (ISP). IRLAB har sitt huvudkontor i Sverige och \u00e4r noterat p\u00e5 Nasdaq Stockholm (IRLAB A). F\u00f6r mer information, bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg den 25 september, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelar idag att f\u00f6retaget kommer att presentera en poster p\u00e5 \u00e5rets upplaga av konferensen International Congress of Parkinson’s Disease and Movement Disorders (MDS) 27 september\u20131 oktober i Philadephia, USA.<\/p>\n","protected":false},"template":"","class_list":["post-11679","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg den 25 september, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelar idag att f\u00f6retaget kommer att presentera en poster p\u00e5 \u00e5rets upplaga av konferensen International Congress of Parkinson's Disease and Movement Disorders (MDS) 27 september\u20131 oktober i Philadephia, USA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/\",\"url\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/\",\"name\":\"IRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2024-09-25T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar vid konferensen International Congress of Parkinson’s Disease and Movement Disorders\u00ae(MDS) 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024 - IRLAB","og_description":"G\u00f6teborg den 25 september, 2024 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelar idag att f\u00f6retaget kommer att presentera en poster p\u00e5 \u00e5rets upplaga av konferensen International Congress of Parkinson's Disease and Movement Disorders (MDS) 27 september\u20131 oktober i Philadephia, USA.","og_url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/","url":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/","name":"IRLAB presenterar vid konferensen International Congress of Parkinson's Disease and Movement Disorders\u00ae(MDS) 2024 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2024-09-25T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-vid-konferensen-international-congress-of-parkinsons-disease-and-movement-disordersmds-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar vid konferensen International Congress of Parkinson’s Disease and Movement Disorders\u00ae(MDS) 2024"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/11679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=11679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}